Editas Medicine, Inc. Common Stock Share Price
NASDAQ: EDITHealthcare
Live Editas Medicine, Inc. Common Stock Share Price Chart
O H L
Editas Medicine, Inc. Common Stock Performance Overview
Days Range
▼
$2.78Low
$2.94High
Markets Today
| Previous Close | $2.71 |
|---|---|
| Open | $2.80 |
| Volume | 1,369,782 |
| Day's Range | $2.78 - $2.94 |
| 52W Range | $1.66 - $4.54 |
| Market Cap | $403.92 M |
Historical Performance
| 1M Returns | -4.58 |
|---|---|
| 3M Returns | +6.27 |
| 6M Returns | +10.16 |
| 1Y Returns | -0.37 |
| 5Y Returns | -95.71 |
| 10Y Returns | -81.63 |
Editas Medicine, Inc. Common Stock Fundamentals
| Market Cap | $403.92 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $40.52 M |
| ROE TTM | -1.98 |
| EPS TTM | $-0.74 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.84 |
| EBITDA | $-94.06 M |
| Profit Margin | -395.01 |
| Market Cap | $403.92 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $40.52 M |
| ROE TTM | -1.98 |
| EPS TTM | $-0.74 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.84 |
| EBITDA | $-94.06 M |
| Profit Margin | -395.01 |
Editas Medicine, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $4.66 M | $3.58 M | $7.54 M | $24.74 M | $2.83 M | $11.89 M |
| Gross Profit + | $4.66 M | $3.58 M | $7.54 M | $24.74 M | $2.83 M | $11.89 M |
| Operating Income | -$76.16 M | -$51.54 M | -$24.55 M | -$7.75 M | -$25.00 M | -$18.55 M |
| EBITDA | -$33.39 M | -$23.63 M | -$23.83 M | -$13.21 M | -$24.52 M | -$19.48 M |
| Interest Expense | -$2.22 M | -$2.02 M | -$2.40 M | $464.00 K | -$1.07 M | -$1.06 M |
| Depreciation | $42.77 M | $27.92 M | $721.00 K | -$5.46 M | $483.00 K | -$923.00 K |
| Income Before Tax | -$76.09 M | -$53.23 M | -$25.12 M | -$5.62 M | -$24.98 M | -$18.23 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$76.09 M | -$53.23 M | -$25.12 M | -$5.62 M | -$24.98 M | -$18.23 M |
| Net Profit Margin | -1633.49% | -1487.84% | -332.98% | -22.72% | -882.44% | -153.32% |
Editas Medicine, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $8.00 K | $9.00 K | $9.00 K | $10.00 K | $10.00 K | $15.00 K |
| Reserve & Surplus | -$1.54 B | -$1.60 B | -$1.62 B | -$1.63 B | -$1.65 B | -$1.67 B |
| Non-Current Liabilities | $128.12 M | $125.45 M | $126.53 M | $113.00 M | $105.15 M | $63.65 M |
| Current Liabilities | $73.11 M | $65.94 M | $61.77 M | $46.25 M | $39.78 M | $68.43 M |
| Total Liabilities | $201.23 M | $191.39 M | $188.30 M | $159.25 M | $144.93 M | $132.08 M |
| Fixed Assets | $8.18 M | $4.58 M | $4.29 M | $3.54 M | $2.88 M | $2.57 M |
| Current Assets | $224.84 M | $182.80 M | $176.89 M | $163.90 M | $128.07 M | $218.07 M |
| Total Assets | $263.65 M | $210.58 M | $201.75 M | $186.53 M | $149.34 M | $237.36 M |
Editas Medicine, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$76.09 M | -$53.23 M | -$25.12 M | -$5.62 M | -$24.98 M | -$18.23 M |
| Operating Cash Flow | -$47.80 M | -$50.21 M | -$30.84 M | -$36.39 M | -$23.06 M | -$29.57 M |
| Investing Cash Flow | $56.39 M | $42.65 M | $39.57 M | $58.00 K | $64.00 K | -$29.80 M |
| Financing Cash Flow | -$1.44 M | $7.41 M | $17.17 M | $17.33 M | $0 | $117.53 M |
| Change in Cash | $7.15 M | -$150.00 K | $25.90 M | -$19.00 M | -$23.00 M | $58.17 M |
Editas Medicine, Inc. Common Stock Return Calculator
The Editas Medicine, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$460
Invested Amount$10,000
Est. Returns$-9,540
About Editas Medicine, Inc. Common Stock
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
Popular Stocks
FAQs
What is the share price of Editas Medicine, Inc. Common Stock today?
Editas Medicine, Inc. Common Stock (EDIT) share price as of September 17, 2026 is $2.91. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Editas Medicine, Inc. Common Stock?
Yes, Indian Investors can invest in the Editas Medicine, Inc. Common Stock (EDIT) Share by opening an international trading account with Angel One.
How can I purchase Editas Medicine, Inc. Common Stock shares in India?
Purchasing Editas Medicine, Inc. Common Stock (EDIT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Editas Medicine, Inc. Common Stock (EDIT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Editas Medicine, Inc. Common Stock?
Yes, you can purchase fractional shares of Editas Medicine, Inc. Common Stock (EDIT) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Editas Medicine, Inc. Common Stock?
The market capitalization of Editas Medicine, Inc. Common Stock on September 17, 2026, is $403.92 M.
In which sector Editas Medicine, Inc. Common Stock belongs?
Editas Medicine, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Editas Medicine, Inc. Common Stock stocks?
In order to invest in Editas Medicine, Inc. Common Stock (EDIT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
